Skip to main content
Clinical Trials/DRKS00030739
DRKS00030739
Not yet recruiting
Not Applicable

Investigation of imaging and neuropsychological biomarkers for aggressive behavior during therapy with the anticonvulsants levetiracetam and perampanel.

niversitätsklinikum der RWTH Aachen0 sites140 target enrollmentNovember 22, 2022
ConditionsG40Epilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G40
Sponsor
niversitätsklinikum der RWTH Aachen
Enrollment
140
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 22, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum der RWTH Aachen

Eligibility Criteria

Inclusion Criteria

  • Patients with a confirmed diagnosis of epilepsy aged 18\-70 years. Furthermore, age\-matched controls without neurological or other severe diseases should be recruited.

Exclusion Criteria

  • Participants are excluded if they are not admissible to MRI.

Outcomes

Primary Outcomes

Not specified

Similar Trials